Rocket Pharmaceuticals Inc RCKT インサイダー取引

Rocket Pharmaceuticals Inc (RCKT) インサイダー取引

フィルター:

日付	保有者名	取引株数	金額レンジ ($)	取引種別	価格レンジ ($)	届出終了時の株数	% 変化
2026-05-21	Dr. Gaurav D. ShahCEO & Director	-55.68k	77.68k	Derivative Exercise and Sale	1.69 - 3.09	1.47M	-
2026-05-21	Dr. Gaurav D. ShahCEO & Director	20.81k	35.18k	Derivative Exercise and Retained Stock	1.69	1.47M	1.44%
2026-05-19	Dr. Gaurav D. ShahCEO & Director	-2.41k	7.26k	売り	3.01	1.45M	-0.17%
2026-05-19	Mr. Martin Louis WilsonGen. Counsel, Secretary, Interim Prin. Financial Officer, Chief Comp. Officer & Chief Corp. Officer	-662.00	2.00k	売り	3.01	677.98k	-0.10%
2026-05-19	Mr. John C. MilitelloVP of Finance, Senior Controller & Treasurer and Principal Accounting Officer	-384.00	1.16k	売り	3.01	89.78k	-0.43%
2026-05-13	Mr. Martin Louis WilsonGen. Counsel, Secretary, Interim Prin. Financial Officer, Chief Comp. Officer & Chief Corp. Officer	-3.36k	12.12k	売り	3.61	678.64k	-0.49%
2026-05-13	Dr. Gaurav D. ShahCEO & Director	-2.73k	9.84k	売り	3.61	1.45M	-0.19%
2026-05-13	Mr. John C. MilitelloVP of Finance, Senior Controller & Treasurer and Principal Accounting Officer	-855.00	3.08k	売り	3.61	90.16k	-0.94%
2026-05-07	Ms. Sarbani ChaudhuriChief Commercial & Medical Affairs Officer	-17.65k	67.74k	売り	3.84	141.59k	-11.08%
2026-02-18	Mr. John C. MilitelloVP of Finance, Senior Controller & Treasurer and Principal Accounting Officer	-1.16k	3.86k	売り	3.34	91.02k	-1.26%
2026-02-18	Dr. Gaurav D. ShahCEO & Director	-5.99k	19.99k	売り	3.34	1.45M	-0.41%
2026-02-18	Mr. Martin Louis WilsonGen. Counsel, Secretary, Interim Prin. Financial Officer, Chief Comp. Officer & Chief Corp. Officer	-1.38k	4.59k	売り	3.34	682.00k	-0.20%
2026-02-13	Mr. Martin Louis WilsonGen. Counsel, Secretary, Interim Prin. Financial Officer, Chief Comp. Officer & Chief Corp. Officer	-12.25k	40.58k	売り	3.31	121.56k	-9.16%
2026-02-13	Mr. John C. MilitelloVP of Finance, Senior Controller & Treasurer and Principal Accounting Officer	-3.73k	12.34k	売り	3.31	92.18k	-3.89%
2026-02-13	Dr. Gaurav D. ShahCEO & Director	-12.28k	40.67k	売り	3.31	1.09M	-1.11%
2026-01-02	Dr. Elisabeth Bjorkインサイダー	10.00k	34.40k	買い	3.44	20.00k	100.00%
2025-11-18	Dr. Jonathan SchwartzChief Science & Gene Therapy Officer	-2.55k	7.59k	売り	2.98	127.19k	-1.96%
2025-11-18	Mr. Martin Louis WilsonGen. Counsel, Secretary, Interim Prin. Financial Officer, Chief Comp. Officer & Chief Corp. Officer	-1.65k	4.91k	売り	2.98	133.82k	-1.22%
2025-11-18	Dr. Gaurav D. ShahCEO & Director	-6.28k	18.72k	売り	2.98	1.18M	-0.53%
2025-11-18	Mr. John C. MilitelloVP of Finance, Senior Controller & Treasurer and Principal Accounting Officer	-1.09k	3.24k	売り	2.98	65.92k	-1.62%
2025-09-19	RTW Investments, LP法人	-1.10M	38.45M	Derivative Exercise and Sale	3.11 - 40.03	18.19M	-
2025-08-27	Dr. Elisabeth Bjorkインサイダー	10.00k	34.10k	買い	3.41	10.00k	-
2025-08-18	Dr. Gaurav D. ShahCEO & Director	-2.23k	6.81k	Sale to Issuer	3.05	1.19M	-0.19%
2025-08-18	Mr. Martin Louis WilsonGen. Counsel, Secretary, Interim Prin. Financial Officer, Chief Comp. Officer & Chief Corp. Officer	-1.59k	4.84k	売り	3.00 - 3.07	135.46k	-1.16%
2025-08-18	Mr. John C. MilitelloVP of Finance, Senior Controller & Treasurer and Principal Accounting Officer	-1.06k	3.22k	売り	3.00 - 3.07	55.92k	-1.86%
2025-08-18	Dr. Jonathan SchwartzChief Science & Gene Therapy Officer	-2.49k	7.56k	売り	3.00 - 3.07	124.66k	-1.95%
2025-08-14	Mr. Martin Louis WilsonGen. Counsel, Secretary, Interim Prin. Financial Officer, Chief Comp. Officer & Chief Corp. Officer	-12.11k	36.56k	売り	3.02	137.05k	-8.12%
2025-08-14	Mr. John C. MilitelloVP of Finance, Senior Controller & Treasurer and Principal Accounting Officer	-7.04k	21.26k	売り	3.02	56.98k	-11.00%
2025-08-14	Dr. Jonathan SchwartzChief Science & Gene Therapy Officer	-11.16k	33.70k	売り	3.02	124.23k	-8.24%
2025-07-03	Mr. Aaron Ondreyインサイダー	-1.48k	4.26k	売り	2.88	10.53k	-12.31%